SANGAMO THERAPEUTICS, INC (SGMOQ)
SEC filings, insider trading & institutional ownership from EDGAR.
Couldn’t find the data you were looking for?
We haven’t added SANGAMO THERAPEUTICS, INC’s filings yet. We add companies and filings all the time.
Track SGMOQ and we’ll email you the moment its filings are in, free and with no account. Or create a free account to request coverage.
Latest filings
10-K, 10-Q, 8-K, Form 4 & 13D/G. Sourced directly from SEC EDGAR
No filings are available yet.
Top holders
13F & 13D/G • latest quarter
| Holder | Filed | Value |
|---|---|---|
| Vanguard Capital Management | May 15, 2026 | $3.14B |
| TWO SIGMA INVESTMENTS, LP | May 15, 2026 | $1.55B |
| BALYASNY ASSET MANAGEMENT L.P. | May 15, 2026 | $1.31B |
| GEODE CAPITAL MANAGEMENT, LLC | May 15, 2026 | $1.13B |
| BlackRock, Inc. | May 13, 2026 | $1.12B |
SGMOQ's filings are public. The insight is one click away.
Scrutar's AI reads every SGMOQ filing and points out what matters. Red flags, risk shifts, disclosure quality and key relationships. Cited to the source, free with an account.
Never miss a SGMOQ filing.
Get an email when SGMOQ files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.
Free foreverNo account requiredOne-click unsubscribe
Data as of Oct 16, 2026Source: SEC EDGAR.